The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer

Abstract

Currently, alcoholic liver disease (ALD) is one of the most prevalent chronic liver diseases worldwide, representing one of the main etiologies of cirrhosis and hepatocellular carcinoma (HCC). Although we do not know the exact mechanisms by which only a selected group of patients with ALD progress to the final stage of HCC, the role of the gut microbiota within the progression to HCC has been intensively studied in recent years. To date, we know that alcohol-induced gut dysbiosis is an important feature of ALD with important repercussions on the severity of this disease. In essence, an increased metabolism of ethanol in the gut induced by an excessive alcohol consumption promotes gut dysfunction and bacterial overgrowth, setting a leaky gut. This causes the translocation of bacteria, endotoxins, and ethanol metabolites across the enterohepatic circulation reaching the liver, where the recognition of the pathogen-associated molecular patterns via specific Toll-like receptors of liver cells will induce the activation of the nuclear factor kappa-B pathway, which releases pro-inflammatory cytokines and chemokines. In addition, the mitogenic activity of hepatocytes will be promoted and cellular apoptosis will be inhibited, resulting in the development of HCC. In this context, it is not surprising that microbiota-regulating drugs have proven effectiveness in prolonging the overall survival of patients with HCC, making attractive the implementation of these drugs as co-adjuvant for HCC treatment.

Keywords

Alcoholic liver disease / gut microbiota / dysbiosis / hepatocellular carcinoma

References

[1] Akinyemiju T,Ahmed M,Alemayohu MA.The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015..JAMA Oncol2017;3:1683-91 PMCID:PMC5824275

[2] WHO. Global status report on alcohol and health 2018. Available from: http://www.who.int/substance_abuse/publications/global_alcohol_report/gsr_2018/en/ [Last accesed on 18 Feb 2020]

[3] Thursz M,Lackner C,Moreno C.EASL clinical practice guidelines: management of alcohol-related liver disease..J Hepatol2018;69:154-81

[4] Teschke R.“Opinion: intestinal microbiome, endotoxins, cytochrome P450 2E1, and the gut-liver axis in alcoholic liver disease”..EC Gastroenterol Dig Syst2019;66-75

[5] Teschke R.Alcoholic liver disease: current mechanistic aspects with focus on their clinical relevance..Biomedicines2019;7: PMCID:PMC6783919

[6] Méndez-Sánchez N,Chávez-Tapia NC,Almeda-Valdés P.Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data..Ann Hepatol2005;4:52-5

[7] Teschke R.Hepatocellular carcinoma in alcoholic liver disease: mechanistic considerations and clinical facts..Hepatoma Res2019;5:40

[8] Motola-Kuba D,Uribe M.Hepatocellular carcinoma. An overview..Ann Hepatol2006;5:16-24

[9] Méndez-Sánchez N,Panduro A,Coronado-Alejandro EU.Current trends of liver cirrhosis in Mexico: similitudes and differences with other world regions..World J Clin Cases2018;6:922-30 PMCID:PMC6288506

[10] Seitz HK,Egerer G.Ethanol metabolism in the gastrointestinal tract and its possible consequences..Alcohol Alcohol Suppl1994;2:157-62

[11] Ganne-Carrié N.Hepatocellular carcinoma in the setting of alcohol-related liver disease..J Hepatol2019;70:284-93

[12] Zhong Z.A unifying hypothesis linking hepatic adaptations for ethanol metabolism to the proinflammatory and profibrotic events of alcoholic liver disease..Alcohol Clin Exp Re2018;42:2072-89 PMCID:PMC6214771

[13] Frank S,Bergmann-Leitner ES,Robert EG.The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis..Dev Cell2001;1:515-25

[14] Palma E,Moreno C,Mudan S.Perturbations in mitochondrial dynamics are closely involved in the progression of alcoholic liver disease..Alcohol Clin Exp Res2020;Epub ahead of print [PMID: 32020641 DOI: 10.1111/acer.14299]

[15] Seitz HK,Lieber CS.Ethanol oxidation by intestinal microsomes: increased activity after chronic ethanol administration..Life Sci1979;25:1443-8

[16] Pronko P,Satanovskaya V,Zimatkin S.Effect of chronic alcohol consumption on the ethanol- and acetaldehyde-metabolizing systems in the rat gastrointestinal tract..Alcohol Alcohol2002;37:229-35

[17] Teschke R.Review article. Biochemical aspects of the hepatic microsomal ethanol-oxidizing system (MEOS): resolved initial controversies and updated molecular views..Biochem Pharmacol (Los Angel)2019;8:267

[18] Lozupone CA,Gordon JI,Knight R.Diversity, stability and resilience of the human gut microbiota..Nature2012;489:220-30 PMCID:PMC3577372

[19] Sender R,Milo R.Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans..Cell2016;164:337-40

[20] Qin J,Raes J,Burgdorf KS.A human gut microbial gene catalogue established by metagenomic sequencing..Nature2010;464:59-65 PMCID:PMC3779803

[21] Cardona F,Tulipani S,Queipo-Ortuño MI.Benefits of polyphenols on gut microbiota and implications in human health..J Nutr Biochem2013;24:1415-22

[22] Stärkel P,de Timary P.Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease..Clin Sci2018;132:199-212

[23] Groschwitz KR.Intestinal barrier function: molecular regulation and disease pathogenesis..J Allergy Clin Immunol2009;124:3-20quiz 21-2 PMCID:PMC4266989

[24] Kim YS.Intestinal goblet cells and mucins in health and disease: recent insights and progress..Curr Gastroenterol Rep2010;12:319-30 PMCID:PMC2933006

[25] Adak A.An insight into gut microbiota and its functionalities..Cell Mol Life Sci2019;76:473-93

[26] Varela-Rey M,Martinez-Chantar ML,Lu SC.Alcohol, DNA methylation, and cancer..Alcohol Res2013;35:25-35 PMCID:PMC3860423

[27] Fabris C,Falleti E,Cussigh A.MTHFR C677T polymorphism and risk of hcc in patients with liver cirrhosis: role of male gender and alcohol consumption..Alcohol Clin Exp Res2009;33:102-7

[28] Saffroy R,Chiappini F,Castera L.The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis..Carcinogenesis2004;25:1443-8

[29] Lu SC.Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer..Alcohol2005;35:227-34

[30] Teschke R.Alcoholic liver disease: alcohol metabolism, cascade of molecular mechanisms, cellular targets, and clinical aspects..Biomedicines2018;6: PMCID:PMC6316574

[31] Hu W,Eveleigh J,Pan J.The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma..Carcinogenesis2002;23:1781-9

[32] Wang Y,Chang B,Zhang D.Effects of alcohol on intestinal epithelial barrier permeability and expression of tight junction-associated proteins..Mol Med Rep2014;9:2352-6

[33] Bull-Otterson L,Kirpich I,Qin X.Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment..PLoS One2013;8:e53028 PMCID:PMC3541399

[34] Wang Y,Liu Y,Barve S.Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury..Am J Pathol2011;179:2866-75 PMCID:PMC3260853

[35] Bajaj JS,Zhao D,Fagan A.Continued alcohol misuse in human cirrhosis is associated with an impaired gut-liver axis..Alcohol Clin Exp Res2017;41:1857-65

[36] Bajaj JS,Hylemon PB,White MB.Altered profile of human gut microbiome is associated with cirrhosis and its complications..J Hepatol2014;60:940-7 PMCID:PMC3995845

[37] Mutlu EA,Rangwala H,Naqvi A.Colonic microbiome is altered in alcoholism..Am J Physiol Gastrointest Liver Physiol2012;302:G966-78 PMCID:PMC3362077

[38] Wang L,Stärkel P,Chen P.Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation..Cell Host Microbe2016;19:227-39 PMCID:PMC4786170

[39] Chen P,Turner JR,Schnabl B.Dysbiosis-induced intestinal inflammation activates TNFRI and mediates alcoholic liver disease in mice..Hepatology2015;61:883-94 PMCID:PMC4340725

[40] Cani PD,Van de Wiele T,Everard A.Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability..Gut2009;58:1091-103 PMCID:PMC2702831

[41] Bode C,Bode JC.Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess..J Hepatol1987;4:8-14

[42] Fukui H,Bode JCh.Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay..J Hepatol1991;12:162-9

[43] Duque Correa MA.Activación alternativa del macrófago: La diversidad en las respuestas de una célula de la inmunidad innata ante la complejidad de los eventos de su ambiente..Inmunologia2007;26:73-86(in Spanish)

[44] Leclercq S,Neyrinck AM,Jamar F.Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects..Brain Behav Immun2012;26:911-8

[45] Grabherr F,Adolph TE,Mayr L.Ethanol-mediated suppression of IL-37 licenses alcoholic liver disease..Liver Int2018;38:1095-101

[46] Zhao JJ,Pan K,Wang QJ.Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57+ NK cells..Sci Rep2015;4:5177 PMCID:PMC4046124

[47] Yu LX.The gut microbiome and liver cancer: mechanisms and clinical translation..Nat Rev Gastroenterol Hepatol2017;14:527-39 PMCID:PMC6467288

[48] Dapito DH,Gwak GY,Jang MK.Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4..Cancer Cell2012;21:504-16 PMCID:PMC3332000

[49] Toyoda H,Uchida D,Isobe T.Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes..J Biol Chem1995;270:7495-500

[50] Uesugi T,Arteel GE,Thurman RG.Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice..Hepatology2001;34:101-8

[51] Adachi Y,Bradford BU,Thurman RG.Antibiotics prevent liver injury in rats following long-term exposure to ethanol..Gastroenterology1995;108:218-24

[52] Yan G,Sun C,Wei H.Chronic alcohol consumption promotes diethylnitrosamine-induced hepatocarcinogenesis via immune disturbances..Sci Rep2017;7:2567 PMCID:PMC5451469

[53] Yoshimoto S,Atarashi K,Sato S.Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome..Nature2013;499:97-101

[54] Xie G,Liu P,Chen W.Distinctly altered gut microbiota in the progression of liver disease..Oncotarget2016;7:19355-66 PMCID:PMC4991388

[55] Grąt M,Patkowski W,Masior Ł.Relevance of pre-transplant α-fetoprotein dynamics in liver transplantation for hepatocellular cancer..Ann Transplant2016;21:115-24

[56] Ren Z,Jiang J,Yu Z.Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma..Gut2019;68:1014-23 PMCID:PMC6580753

[57] Helmink BA,Hermann A,Wargo JA.The microbiome, cancer, and cancer therapy..Nat Med2019;25:377-88

[58] Fox JG,Theve EJ,Fiala JLA.Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens..Gut2010;59:88-97 PMCID:PMC3891362

[59] Rogers AB.Distance burning: how gut microbes promote extraintestinal cancers..Gut Microbes2011;2:52-7 PMCID:PMC3225797

[60] Huang Y,Wang ZM,Tian XF.Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma..J Clin Pathol2004;57:1273-7 PMCID:PMC1770525

[61] Temko JE,Farokhnia M,Cryan JF.The microbiota, the gut and the brain in eating and alcohol use disorders: a “ménage à trois”?.Alcohol Alcohol2017;52:403-13 PMCID:PMC5860274

[62] Bishehsari F,Swanson G,Voigt RM.Alcohol and gut-derived inflammation..Alcohol Res2017;38:163-71 PMCID:PMC5513683

[63] Ling Z,Cheng Y,Jiang H.Decreased diversity of the oral microbiota of patients with hepatitis b virus-induced chronic liver disease: a pilot project..Sci Rep2015;5:17098 PMCID:PMC4660595

[64] El-Serag HB.Hepatocellular carcinoma: epidemiology and molecular carcinogenesis..Gastroenterology2007;132:2557-76

[65] Bajaj JS,Betrapally NS,Fuchs M.HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients..Aliment Pharmacol Ther2016;44:638-43

[66] Maggio R,Andreozzi P,Viscogliosi G.Normocaloric low cholesterol diet modulates Th17/Treg balance in patients with chronic hepatitis C virus infection..PLoS One2014;9:e112346 PMCID:PMC4273946

[67] Preveden T,Milić N,Abenavoli L.Gut microbiota changes and chronic hepatitis C virus infection..Expert Rev Gastroenterol Hepatol2017;11:813-9

[68] Aly AM,El-Gendy AO,Aziz RK.Gut microbiome alterations in patients with stage 4 hepatitis C..Gut Pathog2016;8:42 PMCID:PMC5020480

[69] Scher JU,Longman RS,Ubeda C.Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis..Elife2013;2:e01202 PMCID:PMC3816614

[70] Sousa GM,Andrade LJO,Paraná R.Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection..Cytokine.2012;60:138-42

[71] Kuipers F,Groen AK.Beyond intestinal soap--bile acids in metabolic control..Nat Rev Endocrinol2014;10:488-98

[72] Jia W,Jia W.Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis..Nat Rev Gastroenterol Hepatol2018;15:111-28 PMCID:PMC5899973

[73] Boyer JL,Mennone A,Cai SY.Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents..Am J Physiol Gastrointest Liver Physiol2006;290:G1124-30

[74] Ananthanarayanan M,Makishima M,Suchy FJ.Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor..J Biol Chem2001;276:28857-65

[75] Anwer MS.Intracellular signaling by bile acids..J Biosci (Rajshari)2012;20:1-23 PMCID:PMC4219368

[76] Jung IH,Chung YY,Park YN.Predominant activation of JAK/STAT3 pathway by interleukin-6 is implicated in hepatocarcinogenesis..Neoplasia2015;17:586-97 PMCID:PMC4547407

[77] Nag S,Srivenugopal KS,Zhang R.The MDM2-p53 pathway revisited..J Biomed Res2013;27:254-71 PMCID:PMC3721034

[78] Collado M.Senescence in tumours: evidence from mice and humans..Nat Rev Cancer2010;10:51-7 PMCID:PMC3672965

[79] Coppé JP,Rodier F,Muñoz DP.Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor..PLoS Biol2008;6:2853-68 PMCID:PMC2592359

[80] Nishida S,Nishino N,Koyanagi R.Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese..World J Hepatol2019;11:531-41 PMCID:PMC6603506

[81] Kang SH,Lee JH,Chang Y.Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy..Aliment Pharmacol Ther2017;46:845-55

[82] Elfert A,Soliman S,Abd-Elsalam S.Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis..Eur J Gastroenterol Hepatol2016;28:1450-4

[83] Kalambokis GN,Rodi M,Fotopoulos A.Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites..Clin Gastroenterol Hepatol2012;10:815-8

[84] Vlachogiannakos J,Vasianopoulou P,Karamanolis DG.Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis: rifaximin improves prognosis in cirrhosis..J Gastroenterol Hepatol2013;28:450-5

[85] Shariff MIF,Lewis MR,Mohamed FEZ.Plasma lipid profiling in a rat model of hepatocellular carcinoma: potential modulation through quinolone administration..J Clin Exp Hepatol2015;5:286-94 PMCID:PMC4723654

[86] Ginés P,Planas R,Marco F.Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial..Hepatology1990;12:716-24

[87] Fernández J,Gómez J,Vila J.Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis..Hepatology2002;35:140-8

[88] Li J,Lee N,Pihlajamäki J.Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice..Proc Natl Acad Sci U S A2016;113:E1306-15 PMCID:PMC4780612

[89] Delaune V,Lacotte S,Schrenzel J.Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response..Expert Opin Biol Ther2018;18:1061-71